Sitemap
July 26, 2024 Articles
Filter by Available Specialty
- ‘It’s time for action’: World Hepatitis Day calls to end an ‘entirely preventable disease’
- ‘On the cusp of a new era’: Promising drugs may tackle unmet needs in giant cell arteritis
- Analysis reveals sharp increase in e-bike, scooter injuries
- ASTRO issues updated guideline for symptomatic bone metastases
- Cardiovascular, thromboembolic events more closely tied to kidney vs. glomerular disease
- CBD cream prevents, repairs skin damage from the sun, but not sunscreen substitute
- Cervical dysplasia incidence decreased over 14 years for women younger than 25 years
- Dropless vitrectomy for vitreous hemorrhage controls intraocular inflammation
- Drugs, surgery both effectively lower blood pressure through weight loss
- Endometriosis raises odds of some obstetric outcomes, not preterm birth
- FARE calls for boycott as Mars campaign undoes ‘years of advocacy work’
- FDA approves oral JAK inhibitor Leqselvi for severe alopecia areata in adults
- FDA warns of adverse events due to overdosing of compounded semaglutide
- Findings highlight ‘critical importance’ of infectious complications after CAR-T
- High-intensity laser therapy may reduce patellofemoral pain, improve function
- Hooked on ID with Anurag N. Malani, MD
- Maternal diet, asthma guidelines among latest news in women’s allergy/asthma health
- More severe OSA found in adults with higher homocysteine levels
- Multidisciplinary model can cut refracture risk for hospitalized adults with hip fracture
- Novel immunotherapy creates ‘cancer-fighting cells,’ shrinks colon cancer tumors
- Pneumatic tourniquet use may be associated with improved outcomes of elbow surgery
- Q&A: Many patients unaware of dry eye, treatment options
- Safety, cost and more: The issues PCPs should consider when prescribing GLP-1s
- Slowing diabetic kidney disease progression may cut health costs for veterans
- Social isolation increases risk for death, dementia in older adults
- Study supports testing HIV PrEP users for STIs at 6 months instead of 3
- Study: 0.01% atropine drops slow myopia progression, do not interfere with exotropia
- Study: Body composition associated with neurodegenerative disease, brain aging
- Top in allergy/asthma: Modified anaphylaxis criteria; oral immunotherapy for children
- Up to 13% with dementia may instead have ‘treatable’ HE due to undiagnosed cirrhosis
- VIDEO: Aflibercept 8 mg shows comparable safety to aflibercept 2 mg at 96 weeks